Attendees
Ingrid Saba, PhD
Ingrid Saba is a Senior Solution Executive at Astoriom with a Bachelor of Science (B.Sc.) degree in Microbiology from The Université de Montréal and a solid background in Immunology and Virology having completed both a Master’s (M.Sc.) degree from INRS-Institut Armand Frappier and a Doctor of Philosophy (Ph.D.) degree from the Université de Montréal. As a scientist and a business manager, Ingrid has been supporting research, pre-clinical and clinical scientific community, biotech and pharma companies with highly flexible budgeting and project management solutions.
Jennifer Brown
Jennifer Brown is a Senior Solution Executive at Astoriom. She has a degree in Biology with 25 years of experience consulting with life sciences and diagnostic customers from discovery and clinical research to product commercialization in the areas of donor screening, blood banking, and biorepository services.
Lori A. Ball
Lori A. Ball is a Board Member at Astoriom, with over 30 years of experience as an accomplished executive in the CRO, sample storage, and laboratory research industries, Lori is leading the company’s profitable growth and global expansion in the pharmaceutical, biologics, and medical device industries. Her extensive C-level experience in driving strategic initiatives and operational excellence is inspiring innovation at Astoriom and reinforcing with customers the company’s commitment to excellence in the safeguarding of valuable scientific sample assets.
As the global leader in safeguarding high‑value sample assets, Astoriom will be attending the SCOPE Summit 2025 alongside our digital consent and data integration partner, Embleema. Together, we are building the future of integrated sample management in clinical trials, combining Astoriom’s regulatory-compliant biorepository and stability storage expertise with Embleema’s cutting-edge technology for consent traceability, EHR integration, and metadata enrichment.
SCOPE is a flagship event for clinical trial operations, attracting sponsors, CROs, and research leaders focused on optimising study design, patient engagement, and clinical data integrity. At this year’s summit, we will showcase how Astoriom × Embleema’s joint approach transforms sample oversight by linking physical chain-of-custody data with clinical, consent, and regulatory context, supporting compliant reuse, business continuity, and long-term scientific value.
For clinical research organisations managing complex, multi‑site trials or sensitive sample assets, this collaboration offers a new model for audit‑ready storage, digital interoperability, and end‑to‑end risk mitigation.
Visit us at Stand 1514
More Events
Advanced Therapies Week 2026
San Diego, USA
